Lataa...
Targeting T Cells with Bispecific Antibodies for Cancer Therapy
Bispecific antibodies (BiAbs) offer a unique opportunity to redirect immune effector cells to kill cancer cells. BiAbs combine the benefits of different binding specificities of two monoclonal antibodies (mAbs) into a single construct. This unique feature of BiAbs enables approaches that are not pos...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3792709/ https://ncbi.nlm.nih.gov/pubmed/22050339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11595950-000000000-00000 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|